Osteoporosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The population aged 40-70 years; (2) Those who have risk factors of osteoporosis; (3) Results of IOF 1 minute osteoporosis test are positive; (4) The result of BMD test is reduced(-2.5 <T-value <-1.0); (5) Those with normal or abnormal bone metabolism and biochemical indicators.
Exclusion criteria
Exclusion criteria: (1) People who are known or suspected to be allergic to the drugs of the research; (2) A variety of sports contraindications (acute stages of diseases such as heart and lung diseases, bleeding-prone diseases such as gastrointestinal bleeding); (3) Patients with osteoporosis; (4) Bone metastases from malignant tumors; (5) Long-term use of drugs that affect bone metabolism; (6) Patients who are using other intervention drugs or suffering from other diseases that may interfere with the evaluation of safety or effectiveness of the drug; (7) Patients with severe primary diseases such as cardiovascular, cerebrovascular and hematopoietic diseases, and mental illness, and those who are still taking hormones and those whose results of liver and kidney function tests are abnormal(values higher than the upper limit of normal values); (8) Women preparing for pregnancy,or pregnancy, or lactation; (9) Researchers consider it inappropriate to be selected for this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone metabolism index;Bone mineral density; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale;Improvements in quality of life;Improvements in quality of life;Number of falls;Balance ability test; | — |
Countries
China
Contacts
Bejing University of Chinese Medicine Third Affiliated Hospital